Advanced Search

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 3) (PB 35 of 2015)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
 
PB 35 of 2015
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 3)
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated                26         March 2015
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 3).
         (2)   This Determination may also be cited as PB 35 of 2015.
2              Commencement
                This Determination commences on 1 April 2015.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Albendazole
 
Insert
 
Alemtuzumab
 
[2]     Schedule 1, after item dealing with Amino acids – synthetic, formula
 
Omit
 
Amitriptyline
 
[3]     Schedule 1, after item dealing with Dornase alfa
 
Omit
 
Dorzolamide
 
[4]     Schedule 1, after item dealing with Imatinib
 
Insert
 
IncobotulinumtoxinA
 
[5]     Schedule 1, after item dealing with Midazolam
 
Omit
 
Mifepristone
 
Insert
 
Mifepristone and misoprostol
 
[6]     Schedule 1, after item dealing with Nedocromil
 
Omit
 
Nicorandil
 
[7]     Schedule 1, after item dealing with Oestriol
 
Insert
 
Ofatumumab
 
 
[8]     Schedule 1, after item dealing with Oxprenolol
 
Insert
 
Oxytocin
 
[9]     Schedule 1, after item dealing with Strontium
 
Insert
 
Sucroferric oxyhydroxide
 
[10]   Schedule 1, after item dealing with Umeclidinium
 
Omit
 
Ursodeoxycholic acid
 
[11]   Schedule 2, after item dealing with Amisulpride
 
Insert
 
Amitriptyline
 
[12]   Schedule 2, after item dealing with Donepezil
 
Insert
 
Dorzolamide
 
[13]   Schedule 2, after item dealing with Mirtazapine
 
Omit
 
Misoprostol
 
[14]   Schedule 2, after item dealing with Nevirapine
 
Insert
 
Nicorandil
 
[15]   Schedule 2, after item dealing with Tropisetron
 
Insert
 
Ursodeoxycholic acid